Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Significance of the FSH Receptor Polymorphism p.N680S for the Efficacy of FSH Therapy of Idiopathic Male Infertility: a Pharmacogenetic Approach

NCT02349945 is registered in ClinicalTrials.gov with Azienda USL Modena as lead sponsor.

NCT NCT02349945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02349945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Significance of the FSH Receptor Polymorphism p.N680S for the Efficacy of FSH Therapy of Idiopathic Male Infertility: a Pharmacogenetic Approach
Lead sponsor
Azienda USL Modena
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2015
Enrollment
88 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

male infertility